Purple Biotech (PPBT) Cash from Discontinued Operations (2020 - 2021)
Purple Biotech (PPBT) posted quarterly Cash from Discontinued Operations of 374000.0 for Q4 2021, up 48.41% year-over-year from 251998.14 in Q4 2020, and down 1033.33% quarter-over-quarter from 33000.0 in Q3 2021.
Purple Biotech (PPBT) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends
Purple Biotech (PPBT) has reported Cash from Discontinued Operations for 2 consecutive years, with 374000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Cash from Discontinued Operations rose 48.41% year-over-year to 374000.0; the TTM figure through Dec 2021 stood at 538000.0 (changed N/A YoY), while the FY2021 annual figure was 374000.0, down 121.94% from the prior year.
- Cash from Discontinued Operations slipped to 374000.0 in Q4 2021 per PPBT's latest filing, from 33000.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 24000.0 in Q2 2021 and bottomed at 725000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Purple Biotech | 130.35 | 130.35 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -374,000.00 |
| Dec 31, 2021 | -374,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | -155,000.00 |
| Mar 31, 2021 | -155,000.00 |
| Dec 31, 2020 | -725,000.00 |
| Dec 31, 2020 | -725,000.00 |